A degrader of HER2 and EGFR abolishes p95HER2 and shows robust antitumor efficacy in HER2-positive breast cancer

L Lu Yang A Arup Bhattacharya Y Yun Li D Darrell Peterson Y Yuesheng Zhang

Article Details

Volume / Issue Vol. 16, Issue 1
Published April 20, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (5)

L

Lu Yang

A

Arup Bhattacharya

Y

Yun Li

D

Darrell Peterson

Y

Yuesheng Zhang